E. Becerra

571 total citations
25 papers, 300 citations indexed

About

E. Becerra is a scholar working on Rheumatology, Immunology and Surgery. According to data from OpenAlex, E. Becerra has authored 25 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in E. Becerra's work include Chronic Lymphocytic Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Transplantation: Methods and Outcomes (5 papers). E. Becerra is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Transplantation: Methods and Outcomes (5 papers). E. Becerra collaborates with scholars based in Spain, United Kingdom and South Africa. E. Becerra's co-authors include Maria Leandro, Geraldine Cambridge, Inmaculada de la Torre, Lara Valor, Jonathan Edwards, D. Novitzky, Arturo González‐Quintela, Santiago Tomé, Francisco Gudé and E Barrio and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

E. Becerra

23 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Becerra Spain 9 112 80 80 61 52 25 300
Gonçalo Boleto France 10 87 0.8× 41 0.5× 89 1.1× 75 1.2× 83 1.6× 23 278
A. Nicholas United States 7 103 0.9× 92 1.1× 99 1.2× 22 0.4× 90 1.7× 11 402
Le Goff P France 11 97 0.9× 47 0.6× 213 2.7× 50 0.8× 44 0.8× 63 420
Ravi Rao United Kingdom 5 109 1.0× 102 1.3× 184 2.3× 58 1.0× 75 1.4× 8 336
Nodoka Sekiguchi Japan 12 110 1.0× 79 1.0× 33 0.4× 94 1.5× 63 1.2× 51 407
F Oksman France 11 40 0.4× 46 0.6× 109 1.4× 65 1.1× 32 0.6× 34 295
Anke Rosemann Germany 7 59 0.5× 98 1.2× 157 2.0× 107 1.8× 59 1.1× 7 295
X. Mariette France 2 68 0.6× 61 0.8× 195 2.4× 71 1.2× 28 0.5× 3 374
Malini Bhole United Kingdom 6 125 1.1× 66 0.8× 29 0.4× 31 0.5× 17 0.3× 11 294
Nashla Barroso United States 4 109 1.0× 26 0.3× 107 1.3× 61 1.0× 18 0.3× 7 324

Countries citing papers authored by E. Becerra

Since Specialization
Citations

This map shows the geographic impact of E. Becerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Becerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Becerra more than expected).

Fields of papers citing papers by E. Becerra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Becerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Becerra. The network helps show where E. Becerra may publish in the future.

Co-authorship network of co-authors of E. Becerra

This figure shows the co-authorship network connecting the top 25 collaborators of E. Becerra. A scholar is included among the top collaborators of E. Becerra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Becerra. E. Becerra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loricera, J., D. Prieto-Peña, Susana Romero-Yuste, et al.. (2024). Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature. Arthritis Research & Therapy. 26(1). 116–116. 5 indexed citations
2.
3.
Calderón-Goercke, Monica, Santos Castañeda, Ignacio Villa, et al.. (2021). Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients. Seminars in Arthritis and Rheumatism. 51(2). 387–394. 17 indexed citations
4.
Becerra, E., Inmaculada de la Torre, Maria Leandro, & Geraldine Cambridge. (2017). B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets. Clinical & Experimental Immunology. 190(3). 372–383. 18 indexed citations
5.
Becerra, E., et al.. (2014). Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura. Clinical & Experimental Immunology. 179(3). 414–425. 18 indexed citations
6.
Becerra, E., Geraldine Cambridge, & Maria Leandro. (2013). FRI0228 Safety and efficacy of rituximab in patients with rheumatoid arthritis and lung involvement. Annals of the Rheumatic Diseases. 72. A450–A450. 11 indexed citations
7.
Becerra, E., et al.. (2012). SAFETY AND EFFICACY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND LUNG INVOLVEMENT. UCL Discovery (University College London). 1 indexed citations
8.
Torre, Inmaculada de la, Maria Leandro, Lara Valor, et al.. (2012). Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics. Lara D. Veeken. 51(5). 833–840. 77 indexed citations
9.
Becerra, E., Geraldine Cambridge, Inmaculada de la Torre, & Maria Leandro. (2012). Long-term safety of rituximab in patients with rheumatoid arthritis. International Journal of Clinical Rheumatology. 7(4). 383–390. 8 indexed citations
10.
Leandro, Maria & E. Becerra. (2011). B-cell therapies in established rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 25(4). 535–548. 29 indexed citations
11.
Calvo, E., E. Becerra, FJ López-Longo, et al.. (2010). Pericardial tamponade in a patient with polymyalgia rheumatica.. PubMed. 27(1 Suppl 52). S83–5. 5 indexed citations
12.
Herreras, José M., et al.. (2004). Presentación ocular de la granulomatosis de Wegener. Archivos de la Sociedad Española de Oftalmología. 79(3). 135–8. 3 indexed citations
13.
Franco, J. Campos, Christophe Rey, E. Becerra, & Arturo González‐Quintela. (2002). Fallo hepático fulminante asociado al uso de cocaína. Anales de Medicina Interna. 19(7). 365–7. 7 indexed citations
14.
González‐Quintela, Arturo, Carmen Vidal, Francisco Gudé, et al.. (1995). Increased serum IgE in alcohol abusers. Clinical & Experimental Allergy. 25(8). 756–764. 42 indexed citations
15.
Eiras, A., et al.. (1991). [Toxic hepatitis from cinchophen: report of 3 cases].. PubMed. 97(3). 104–6. 7 indexed citations
16.
Mosteiro, Mar, et al.. (1990). Carcinoides bronquiales: estudio clínico, histopatológico e inmunohistoquímico. Archivos de Bronconeumología. 26(1). 12–16. 3 indexed citations
17.
Reichenspurner, H., David K. C. Cooper, John A. Odell, et al.. (1989). Heart Transplantation in Cape Town — A Review of Twenty Years’ Experience. 425–436.
18.
Novitzky, D., et al.. (1987). Early donor heart failure following transplantation from myocardial injury sustained during brain death. Clinical Transplantation. 1(2). 108–113. 5 indexed citations
19.
Cooper, Deborah K., et al.. (1986). Are there Indications for Heterotopic Heart Transplantation in 1986?. The Thoracic and Cardiovascular Surgeon. 34(5). 300–304. 23 indexed citations
20.
Taboada, Eugenio, et al.. (1986). [Whipple's disease associated with liver deposits of alpha-1 antitrypsin (Pi MS phenotype) and melena].. PubMed. 70(5). 443–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gonçalo Boleto Breakdown of academic impact, for papers by A. Nicholas Breakdown of academic impact, for papers by Le Goff P Breakdown of academic impact, for papers by Ravi Rao Breakdown of academic impact, for papers by Nodoka Sekiguchi Breakdown of academic impact, for papers by F Oksman Breakdown of academic impact, for papers by Anke Rosemann Breakdown of academic impact, for papers by X. Mariette Breakdown of academic impact, for papers by Malini Bhole Breakdown of academic impact, for papers by Nashla Barroso
Rankless by CCL
2026